Lexicon Pharmaceuticals | LXRX - Market Capitalization


Lexicon Pharmaceuticals reported $421.1M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Akebia Therapeutics USD 502M 75M Mar/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Coherus Biosciences USD 94M 65M Mar/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Halozyme Therapeutics USD 7.91B 664M Dec/2025
Illumina USD 20.62B 6.53B Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
MacroGenics USD 106M 29M Sep/2025
MannKind USD 1.74B 93M Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vanda Pharmaceuticals USD 279M 6M Dec/2024